Expanding antiviral therapy for chronic hepatitis B: scale up screening and treatment
10.3760/cma.j.cn501113-20221018-00497
- VernacularTitle:扩大慢性乙型肝炎抗病毒治疗：更多筛查，更多治疗
- Author:
Mengyang ZHANG
1
;
Yameng SUN
;
Hong YOU
Author Information
1. 首都医科大学附属北京友谊医院肝病中心，北京 100050
- Keywords:
Chronic hepatitis B;
Antiviral therapy;
Indication
- From:
Chinese Journal of Hepatology
2022;30(11):1133-1136
- CountryChina
- Language:Chinese
-
Abstract:
The Chinese Society of Hepatology, Chinese Medical Association published "Expert Opinions on Expanding Antiviral Therapy for Chronic Hepatitis B" in 2022, with a focus on "active screening of the existing patients, paying attention to the potential risk of disease progression, and active intervening of the low level viremia," and recommended that specific actions be taken to further optimize the expanding screening, widening the antiviral indications, and scale up the diagnosis and treatment of low level viremia.
